{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:49:51Z","timestamp":1762249791272,"version":"3.44.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41374-021-00696-1","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T05:02:23Z","timestamp":1636779743000},"page":"341-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression"],"prefix":"10.1016","volume":"102","author":[{"given":"Jun-Yu","family":"Huo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Geng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Jun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-021-00696-1_bib1","doi-asserted-by":"crossref","first-page":"108086","DOI":"10.1016\/j.diabres.2020.108086","article-title":"Mortality attributable to diabetes in 20\u201379 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"162","author":"Saeedi","year":"2020","journal-title":"Diabetes Res. Clin. Pract"},{"key":"10.1038\/s41374-021-00696-1_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1038\/s41374-021-00696-1_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1038\/s41374-021-00696-1_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol"},{"key":"10.1038\/s41374-021-00696-1_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ. Res."},{"key":"10.1038\/s41374-021-00696-1_bib6","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/ijms21072413","article-title":"Role of oxidative stress in metabolic and subcellular abnormalities in diabetic cardiomyopathy","volume":"21","author":"Dhalla","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1038\/s41374-021-00696-1_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc Res."},{"key":"10.1038\/s41374-021-00696-1_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2020.08.015","article-title":"Disruption of energy utilization in diabetic cardiomyopathy; a mini review","volume":"54","author":"Nirengi","year":"2020","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1038\/s41374-021-00696-1_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvr212","article-title":"Lipotoxicity in type 2 diabetic cardiomyopathy","volume":"92","author":"van de Weijer","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1038\/s41374-021-00696-1_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fendo.2018.00642","article-title":"Chronic O-glcNAcylation and diabetic cardiomyopathy: the bitterness of glucose","volume":"9","author":"Ducheix","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1038\/s41374-021-00696-1_bib11","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1152\/ajpcell.00006.2014","article-title":"Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart","volume":"307","author":"Pham","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1038\/s41374-021-00696-1_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1038\/s41374-021-00696-1_bib13","doi-asserted-by":"crossref","first-page":"101338","DOI":"10.1016\/j.arr.2021.101338","article-title":"Autophagy in the diabetic heart: a potential pharmacotherapeutic target in diabetic cardiomyopathy","volume":"68","author":"Dewanjee","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1038\/s41374-021-00696-1_bib14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/s41374-021-00696-1_bib15","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.jacc.2018.08.2186","article-title":"Renal denervation prevents heart failure progression via inhibition of the renin-angiotensin system","volume":"72","author":"Sharp","year":"2018","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1038\/s41374-021-00696-1_bib16","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2017.08.056","article-title":"Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney","volume":"70","author":"Polhemus","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1038\/s41374-021-00696-1_bib17","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","article-title":"Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY registry","volume":"40","author":"Mahfoud","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1038\/s41374-021-00696-1_bib18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41374-021-00696-1_bib19","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00125-015-3771-9","article-title":"Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats","volume":"58","author":"Rafiq","year":"2015","journal-title":"Diabetologia"},{"key":"10.1038\/s41374-021-00696-1_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/biomedicines8030043","article-title":"Comparative study of the effects of GLP1 analog and SGLT2 inhibitor against diabetic cardiomyopathy in type 2 diabetic rats: possible underlying mechanisms","volume":"8","author":"Hussein","year":"2020","journal-title":"Biomedicines"},{"key":"10.1038\/s41374-021-00696-1_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","article-title":"Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy","volume":"19","author":"Arow","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1038\/s41374-021-00696-1_bib22","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"10.1038\/s41374-021-00696-1_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12933-019-0849-6","article-title":"The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats","volume":"18","author":"Lee","year":"2019","journal-title":"Cardiovasc Diabetol."},{"key":"10.1038\/s41374-021-00696-1_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/SLA.0b013e3182890311","article-title":"Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes","volume":"258","author":"Jurowich","year":"2013","journal-title":"Ann. Surg"},{"key":"10.1038\/s41374-021-00696-1_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/laban0311-85","article-title":"Analgesic effects of tramadol, carprofen or multimodal analgesia in rats undergoing ventral laparotomy","volume":"40","author":"Zegre Cannon","year":"2011","journal-title":"Lab. Anim."},{"key":"10.1038\/s41374-021-00696-1_bib26","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1159\/000489653","article-title":"Renal denervation effects on myocardial fibrosis and ventricular arrhythmias in rats with ischemic cardiomyopathy","volume":"46","author":"Zhang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1038\/s41374-021-00696-1_bib27","doi-asserted-by":"crossref","first-page":"e81296","DOI":"10.1371\/journal.pone.0081296","article-title":"Decreased autophagy in rat heart induced by anti-\u03b21-adrenergic receptor autoantibodies contributes to the decline in mitochondrial membrane potential","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/s41374-021-00696-1_bib28","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1074\/jbc.RA118.005767","article-title":"EPHB6 controls catecholamine biosynthesis by up-regulating tyrosine hydroxylase transcription in adrenal gland chromaffin cells","volume":"294","author":"Shi","year":"2019","journal-title":"J. Biol. Chem"},{"key":"10.1038\/s41374-021-00696-1_bib29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/eurheartj\/ehs041","article-title":"The human sympathetic nervous system: its relevance in hypertension and heart failure","volume":"33","author":"Parati","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1038\/s41374-021-00696-1_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1038\/s41374-021-00696-1_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/cvr\/cvx018","article-title":"Metabolic remodeling in diabetic cardiomyopathy","volume":"113","author":"Chong","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1038\/s41374-021-00696-1_bib32","doi-asserted-by":"crossref","first-page":"165775","DOI":"10.1016\/j.bbadis.2020.165775","article-title":"Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance","volume":"1866","author":"Luiken","year":"2020","journal-title":"Biochim Biophys. Acta. Mol. Basis Dis."},{"key":"10.1038\/s41374-021-00696-1_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4093\/dmj.2018.0101","article-title":"Role of the pyruvate dehydrogenase complex in metabolic remodeling: differential pyruvate dehydrogenase complex functions in metabolism","volume":"42","author":"Park","year":"2018","journal-title":"Diabetes Metab. J"},{"key":"10.1038\/s41374-021-00696-1_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1038\/s41374-021-00696-1_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"10.1038\/s41374-021-00696-1_bib36","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/HJH.0000000000001434","article-title":"Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2","volume":"35","author":"Matthews","year":"2017","journal-title":"J. Hypertens"},{"key":"10.1038\/s41374-021-00696-1_bib37","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00125-020-05145-0","article-title":"Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes","volume":"63","author":"Gueguen","year":"2020","journal-title":"Diabetologia"},{"key":"10.1038\/s41374-021-00696-1_bib38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jash.2017.07.005","article-title":"The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus","volume":"11","author":"Jordan","year":"2017","journal-title":"J. Am. Soc. Hypertens"},{"key":"10.1038\/s41374-021-00696-1_bib39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl. Sci"},{"key":"10.1038\/s41374-021-00696-1_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12933-017-0643-2","article-title":"Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking","volume":"17","author":"Ram\u00edrez","year":"2018","journal-title":"Cardiovasc. Diabetol"},{"key":"10.1038\/s41374-021-00696-1_bib41","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J. Physiol."},{"key":"10.1038\/s41374-021-00696-1_bib42","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV protection in the EMPA-REG outcome trial: a \u201cThrifty Substrate\u201d hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1038\/s41374-021-00696-1_bib43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/cvr\/cvz104","article-title":"Ketone body can be a fuel substrate for failing heart","volume":"115","author":"Nakamura","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1038\/s41374-021-00696-1_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1074\/jbc.M808518200","article-title":"Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose","volume":"284","author":"Hu","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1038\/s41374-021-00696-1_bib45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00395-011-0156-1","article-title":"A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart","volume":"106","author":"Cole","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1038\/s41374-021-00696-1_bib46","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.3390\/ijms21144962","article-title":"The mitochondria: a target of polyphenols in the treatment of diabetic cardiomyopathy","volume":"21","author":"Bhagani","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00696-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00696-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00696-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:23:42Z","timestamp":1758396222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0023683722000484"],"URL":"https:\/\/doi.org\/10.1038\/s41374-021-00696-1","relation":{},"ISSN":["0023-6837"],"issn-type":[{"type":"print","value":"0023-6837"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-021-00696-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}